Pharmaceuticals stocks
9 US-listed companies in pharmaceuticals, part of the Health Care sector, with a combined market value of $2.91 trillion at the close on Oct 30, 2026. Their median P/E is 40.8 and their median one-year return +43.0%.
Pharmaceuticals stocks, largest first
| Company | Price | 1 year | Market value | P/E |
|---|---|---|---|---|
| Eli LillyLLY | $1,418 | +68.9% | $1.33T | 46.0 |
| Johnson & JohnsonJNJ | $273.20 | +47.8% | $658B | 41.5 |
| MerckMRK | $149.52 | +78.4% | $369B | 119.6 |
| Novo NordiskNVO | $40.00 | -16.2% | $178B | 9.9 |
| PfizerPFE | $30.52 | +34.5% | $174B | 40.2 |
| Bristol Myers SquibbBMY | $62.48 | +43.0% | $128B | 13.8 |
| ZoetisZTS | $79.72 | -43.2% | $33.4B | 13.0 |
| ViatrisVTRS | $19.04 | +90.1% | $22.2B | — |
| Corcept TherapeuticsCORT | $81.12 | +12.3% | $8.71B | 193.1 |
No forecast, no recommendation. A list of companies by industry is not advice to buy, sell or hold any of them.